564 related articles for article (PubMed ID: 32981205)
1. Cellular senescence in cancer: from mechanisms to detection.
Ou HL; Hoffmann R; González-López C; Doherty GJ; Korkola JE; Muñoz-Espín D
Mol Oncol; 2021 Oct; 15(10):2634-2671. PubMed ID: 32981205
[TBL] [Abstract][Full Text] [Related]
2. The role of cellular senescence and SASP in tumour microenvironment.
Takasugi M; Yoshida Y; Hara E; Ohtani N
FEBS J; 2023 Mar; 290(5):1348-1361. PubMed ID: 35106956
[TBL] [Abstract][Full Text] [Related]
3. Pro- and anti-tumorigenic functions of the senescence-associated secretory phenotype.
Lau L; David G
Expert Opin Ther Targets; 2019 Dec; 23(12):1041-1051. PubMed ID: 30616404
[No Abstract] [Full Text] [Related]
4. Overcoming the senescence-associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer.
Chambers CR; Ritchie S; Pereira BA; Timpson P
Mol Oncol; 2021 Dec; 15(12):3242-3255. PubMed ID: 34137158
[TBL] [Abstract][Full Text] [Related]
5. Effects of senescence on the tumour microenvironment and response to therapy.
Reynolds LE; Maallin S; Haston S; Martinez-Barbera JP; Hodivala-Dilke KM; Pedrosa AR
FEBS J; 2024 Jun; 291(11):2306-2319. PubMed ID: 37873605
[TBL] [Abstract][Full Text] [Related]
6. Cellular senescence and the tumour microenvironment.
Takasugi M; Yoshida Y; Ohtani N
Mol Oncol; 2022 Sep; 16(18):3333-3351. PubMed ID: 35674109
[TBL] [Abstract][Full Text] [Related]
7. Exosomes as Emerging Pro-Tumorigenic Mediators of the Senescence-Associated Secretory Phenotype.
Jakhar R; Crasta K
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137607
[TBL] [Abstract][Full Text] [Related]
8. Senescence-associated IL-6 and IL-8 cytokines induce a self- and cross-reinforced senescence/inflammatory milieu strengthening tumorigenic capabilities in the MCF-7 breast cancer cell line.
Ortiz-Montero P; Londoño-Vallejo A; Vernot JP
Cell Commun Signal; 2017 May; 15(1):17. PubMed ID: 28472950
[TBL] [Abstract][Full Text] [Related]
9. Reshaping of the tumor microenvironment by cellular senescence: An opportunity for senotherapies.
D'Ambrosio M; Gil J
Dev Cell; 2023 Jun; 58(12):1007-1021. PubMed ID: 37339603
[TBL] [Abstract][Full Text] [Related]
10. Senescence and Immunotherapy: Redundant Immunomodulatory Pathways Promote Resistance.
Oesterreich S; Aird KM
Cancer Immunol Res; 2023 Apr; 11(4):401-404. PubMed ID: 36826438
[TBL] [Abstract][Full Text] [Related]
11. [Tumor-immune cell interaction and senescence-associated molecules in colorectal carcinoma].
Kellers F
Pathologie (Heidelb); 2023 Dec; 44(Suppl 3):113-120. PubMed ID: 38038733
[TBL] [Abstract][Full Text] [Related]
12. Senescent cells and their secretory phenotype as targets for cancer therapy.
Velarde MC; Demaria M; Campisi J
Interdiscip Top Gerontol; 2013; 38():17-27. PubMed ID: 23503512
[TBL] [Abstract][Full Text] [Related]
13. The impact of the senescent microenvironment on tumorigenesis: Insights for cancer therapy.
Zhang W; Zhang K; Shi J; Qiu H; Kan C; Ma Y; Hou N; Han F; Sun X
Aging Cell; 2024 May; 23(5):e14182. PubMed ID: 38650467
[TBL] [Abstract][Full Text] [Related]
14. Biological functions of therapy-induced senescence in cancer.
Fitsiou E; Soto-Gamez A; Demaria M
Semin Cancer Biol; 2022 Jun; 81():5-13. PubMed ID: 33775830
[TBL] [Abstract][Full Text] [Related]
15. The Jekyll and Hyde of Cellular Senescence in Cancer.
Demirci D; Dayanc B; Mazi FA; Senturk S
Cells; 2021 Jan; 10(2):. PubMed ID: 33494247
[TBL] [Abstract][Full Text] [Related]
16. Genes and pathways involved in senescence bypass identified by functional genetic screens.
Roupakia E; Markopoulos GS; Kolettas E
Mech Ageing Dev; 2021 Mar; 194():111432. PubMed ID: 33422562
[TBL] [Abstract][Full Text] [Related]
17. Assessing Functional Roles of the Senescence-Associated Secretory Phenotype (SASP).
Malaquin N; Tu V; Rodier F
Methods Mol Biol; 2019; 1896():45-55. PubMed ID: 30474839
[TBL] [Abstract][Full Text] [Related]
18. Quantitative Analysis of Cellular Senescence in Culture and In Vivo.
Zhao J; Fuhrmann-Stroissnigg H; Gurkar AU; Flores RR; Dorronsoro A; Stolz DB; St Croix CM; Niedernhofer LJ; Robbins PD
Curr Protoc Cytom; 2017 Jan; 79():9.51.1-9.51.25. PubMed ID: 28055114
[TBL] [Abstract][Full Text] [Related]
19. Senescence-Associated Molecules and Tumor-Immune-Interactions as Prognostic Biomarkers in Colorectal Cancer.
Kellers F; Fernandez A; Konukiewitz B; Schindeldecker M; Tagscherer KE; Heintz A; Jesinghaus M; Roth W; Foersch S
Front Med (Lausanne); 2022; 9():865230. PubMed ID: 35492321
[TBL] [Abstract][Full Text] [Related]
20. Distinct phenotypes and 'bystander' effects of senescent tumour cells induced by docetaxel or immunomodulatory cytokines.
Sapega O; Mikyšková R; Bieblová J; Mrázková B; Hodný Z; Reiniš M
Int J Oncol; 2018 Nov; 53(5):1997-2009. PubMed ID: 30226595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
